Advertisement

Case report of primary dural lymphoma mimicking a cerebellar meningioma and brief review of literature

  • Salvatore D’OriaEmail author
  • Mariagrazia Dibenedetto
  • Eleonora Squillante
  • Rosa Maria Bona
  • Carlo Somma
  • Umberto Godano
Original article

Abstract

Primary dural lymphoma (PDL) is an extremely rare subtype of primary central nervous system lymphoma arising from the dura mater in absence of systemic disease. The most common histological type is the low-grade marginal zone lymphoma, whereas high-grade lymphomas are unusual. We present a case of primary diffuse large B-cell lymphoma, presenting as PDL in the posterior fossa, originating from the dura mater of the petrous bone covering the surface of the left cerebellum, a location not previously described. A 65-year-old woman presented with sudden onset of severe dizziness was admitted in otolaryngology department then transferred to neurosurgery ward. CT scan revealed a large lesion involving left cerebellum, subsequent MRI of the brain demonstrated an enhancing mass suggestive for petrous bone meningioma. The tumor was excised, and the histopathological examination unexpectedly revealed a diffuse large B-cell lymphoma. The patient received postoperative chemoradiotherapy. 20 months after surgery a good outcome was registered. Due to the rarity of primary dural lymphomas no standard treatment is available, however, gross total or subtotal resection followed by adjuvant therapy seems to be a good choice to manage the pathology.

Keywords

Dural lymphoma Cerebellum Petrous bone Neurosurgery 

Notes

Funding

None.

Compliance with ethical standards

Conflict of interest

The authors report no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    Ervin T, Canellos GP (1980) Successful treatment of recurrent primary central nervous system lymphoma with high-dose methotrexate. Cancer 45(7):1556–1557CrossRefGoogle Scholar
  2. 2.
    Abrey LE, Yahalom J, DeAngelis LM (2000) Treatment for primary CNS lymphoma: the next step. J Clin Oncol 18(17):3144–3150CrossRefGoogle Scholar
  3. 3.
    Plotkin S, Batchelor T (2001) Primary nervous system lymphoma. Lancet Oncol 2:354–365CrossRefGoogle Scholar
  4. 4.
    Iwamoto FM, DeAngelis LM, Abrey LE (2006) Primary dural lymphomas: a clinicopathologic study of treatment and outcome in eight patients. Neurology 66(11):1763–1765CrossRefGoogle Scholar
  5. 5.
    Venkataraman G et al (2011) Marginal zone lymphomas involving meningeal dura: possible link to IgG4-related diseases. Mod Pathol 24(3):355CrossRefGoogle Scholar
  6. 6.
    DeAngelis LM (2001) Brain tumors. N Engl J Med 344(2):114–123CrossRefGoogle Scholar
  7. 7.
    Tu PH, Giannini C, Judkins AR, Schwalb JM, Burack R, O’neill BP, Yachnis AT, Burger PC, Scheithauer BW, Perry A (2005) Clinicopathologic and genetic profile of intracranial marginal zone lymphoma: a primary low-grade CNS lymphoma that mimics meningioma. J Clin Oncol 23(24):5718–5727CrossRefGoogle Scholar
  8. 8.
    Ferreri AJ, Abrey LE, Blay JY, Borisch B, Hochman J, Neuwelt EA, Yahalom J, Zucca E, Cavalli F, Armitage J, Batchelor T (2003) Summary statement on primary central nervous system lymphomas from the Eighth International Conference on Malignant Lymphoma, Lugano, Switzerland, June 12 to 15, 2002. J Clin Oncol 21(12):2407–2414CrossRefGoogle Scholar
  9. 9.
    Murray K, Kun L, Cox J (1986) Primary malignant lymphoma of the central nervous system: results of treatment of 11 cases and review of the literature. J Neurosurg 65(5):600–607CrossRefGoogle Scholar
  10. 10.
    Iwamoto FM, Abrey LE (2006) Primary dural lymphomas: a review. Neurosurg Focus 21(5):1–5CrossRefGoogle Scholar
  11. 11.
    Yamada SM, Ikawa N, Toyonaga S, Nakabayashi H, Park KC, Shimizu K (2006) Primary malignant B-cell–type dural lymphoma: case report. Surg Neurol 66(5):539–543CrossRefGoogle Scholar
  12. 12.
    Ferracini R, Pileri S, Bergmann M, Sabattini E, Rigobello L, Gambacorta M, Galli C, Manetto V, Frank G, Godano U et al (1993) Non-Hodgkin lymphomas of the central nervous system: clinico-pathologic and immunohistochemical study of 147 cases. Pathol Res Pract 189(3):249–260CrossRefGoogle Scholar
  13. 13.
    Isaacson PG, Du MQ (2004) MALT lymphoma: from morphology to molecules. Nat Rev Cancer 4(8):644CrossRefGoogle Scholar
  14. 14.
    Said R, Rizk S, Dai Q (2011) Clinical challenges of primary diffuse large B-cell lymphoma of the dura: case report and literature review. ISRN Hematol 2011:945212CrossRefGoogle Scholar
  15. 15.
    Goetz P, Lafuente J, Revesz T, Galloway M, Dogan A, Kitchen N (2002) Primary low-grade B-cell lymphoma of mucosa-associated lymphoid tissue of the dura mimicking the presentation of an acute subdural hematoma: case report and review of the literature. J Neurosurg 96(3):611–614CrossRefGoogle Scholar
  16. 16.
    Jacobs AH, Kracht LW, Gossmann A, Rüger MA, Thomas AV, Thiel A, Herholz K (2005) Imaging in neurooncology. NeuroRx 2(2):333–347CrossRefGoogle Scholar
  17. 17.
    Jamjoom AB, Jamjoom ZAB, Cheema MA (1998) Primary midline cranial vault lymphoma simulating a parasagittal meningioma: the role of angiography in preoperative diagnosis. Neurosurg Rev 21(2):202–205CrossRefGoogle Scholar
  18. 18.
    Johnson MD, Powell SZ, Boyer PJ, Weil RJ, Moots PL (2002) Dural lesions mimicking meningiomas. Hum Pathol 33(12):1211–1226CrossRefGoogle Scholar
  19. 19.
    Iaccarino C, Schiavi P, Crafa P, Bronzoni C, Ramponi V, Mantenuto G, Cavanna L, Servadei F (2013) Primary dural lymphoma mimicking a chronic epidural hematoma. Differential diagnosis of two rare conditions. Clin Neurol Neurosurg 115(8):1510–1513CrossRefGoogle Scholar
  20. 20.
    Nishimoto T, Yuki K, Sasaki T, Imada Y, Murakami T, Kodama Y (2003) A case of subcutaneous malignant lymphoma with dura mater lesion. No shinkei geka. Neurol Surg 31(1):43–47Google Scholar
  21. 21.
    DeAngelis LM, Seiferheld W, Schold SC, Fisher B, Schultz CJ (2002) Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10. J Clin Oncol 20(24):4643–4648CrossRefGoogle Scholar
  22. 22.
    Giordano A, Perrone T, Guarini A, Ciappetta P, Rubini G, Ricco R, Palma M, Specchia G, Liso V (2007) Primary intracranial dural B cell small lymphocytic lymphoma. Leuk Lymphoma 48(7):1437–1443CrossRefGoogle Scholar
  23. 23.
    Freudenstein D, Bornemann A, Ernemann U, Boldt R, Duffner F (2000) Intracranial malignant B-cell lymphoma of the dura. Clin Neuropathol 19(1):34–37Google Scholar
  24. 24.
    Adams HJ, Nievelstein RA, Kwee TC (2015) Prognostic value of complete remission status at end-of-treatment FDG-PET in R-CHOP-treated diffuse large B-cell lymphoma: systematic review and meta-analysis. Br J Haematol 170(2):185–191CrossRefGoogle Scholar

Copyright information

© Belgian Neurological Society 2019

Authors and Affiliations

  • Salvatore D’Oria
    • 1
    Email author
  • Mariagrazia Dibenedetto
    • 1
  • Eleonora Squillante
    • 2
  • Rosa Maria Bona
    • 3
  • Carlo Somma
    • 1
  • Umberto Godano
    • 1
  1. 1.Neurosurgical Unit of Miulli HospitalAcquaviva delle FontiItaly
  2. 2.Neurosurgical Unit of San Giovanni Bosco HospitalNaplesItaly
  3. 3.Pathological Anatomy Unit of Miulli HospitalAcquaviva delle FontiItaly

Personalised recommendations